Home »
The American Association for Cancer Research (AACR) last week led a contingent of 130 organizations, cancer centers, and other...
As infections from SARS-CoV-2 began to rapidly spread across the United States in early 2020, many nonessential medical procedures, including cancer screenings, were...
Editor’s note: This post was written by Nicholas Warren, PhD, science policy program administrator in the AACR’s Office of...
2020 was filled with unexpected challenges for cancer research and patient care. As many of us shifted our lives...
As we approach the end of the year that was consumed by the pandemic, more than 68 million people...
This month, the editors of the AACR’s journals have decided to feature a clinical trial evaluating prolonged treatment with ibrutinib for patients with chronic...
As the COVID-19 pandemic began crossing the globe, scientists from many disciplines anticipated its scope and deployed their research...
“The development of tests that can identify individuals actively infected with SARS-CoV-2 is of obvious and utmost importance for...
At the American Association for Cancer Research (AACR), we know that our mission to prevent and cure all cancers must encompass all...
The COVID-19 pandemic has taken an enormous global toll. Worldwide, nearly 15 million cases of the disease have been reported,...